{"Title": "Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1-42) in human cerebrospinal fluid", "Year": 2016, "Source": "Alzheimer's Dementia", "Volume": "12", "Issue": 5, "Art.No": null, "PageStart": 517, "PageEnd": 526, "CitedBy": 114, "DOI": "10.1016/j.jalz.2015.09.009", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84952053119&origin=inward", "Abstract": "\u00a9 2016 Alzheimer's Association. Published by Elsevier Inc. All rights reserved.Introduction Available assays for quantitation of the Alzheimer's disease (AD) biomarker amyloid-beta 1-42 (A\u03b2 [1-42]) in cerebrospinal fluid demonstrate significant variability and lack of standardization to reference measurement procedures (RMPs). We report analytical performance data for the novel Elecsys \u03b2-amyloid (1-42) assay (Roche Diagnostics). Methods Lot-to-lot comparability was tested using method comparison. Performance parameters were measured according to Clinical & Laboratory Standards Institute (CLSI) guidelines. The assay was standardized to a Joint Committee for Traceability in Laboratory Medicine (JCTLM) approved RMP. Results Limit of quantitation was <11.28 pg/mL, and the assay was linear throughout the measuring range (200-1700 pg/mL). Excellent lot-to-lot comparability was observed (correlation coefficients [Pearson's r] >0.995; bias in medical decision area <2%). Repeatability coefficients of variation (CVs) were 1.0%-1.6%, intermediate CVs were 1.9%-4.0%, and intermodule CVs were 1.1%-3.9%. Estimated total reproducibility was 2.0%-5.1%. Correlation with the RMP was good (Pearson's r, 0.93). Discussion The Elecsys \u03b2-amyloid (1-42) assay has high analytical performance that may improve biomarker-based AD diagnosis.", "AuthorKeywords": ["Alzheimer's disease", "Amyloid", "Amyloid-beta 1-42", "Assay", "Biomarker", "Cerebrospinal fluid", "Dementia", "Diagnosis", "Electrochemiluminescence", "Immunoassay", "Method comparison", "Precision", "Repeatability", "Reproducibility", "Variability"], "IndexKeywords": ["Alzheimer Disease", "Amyloid beta-Peptides", "Biomarkers", "Humans", "Immunoassay", "Luminescence", "Peptide Fragments", "Reference Standards", "Reproducibility of Results"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84952053119", "SubjectAreas": [["Epidemiology", "MEDI", "2713"], ["Health Policy", "MEDI", "2719"], ["Developmental Neuroscience", "NEUR", "2806"], ["Neurology (clinical)", "MEDI", "2728"], ["Geriatrics and Gerontology", "MEDI", "2717"], ["Psychiatry and Mental Health", "MEDI", "2738"], ["Cellular and Molecular Neuroscience", "NEUR", "2804"]], "AuthorData": {"16644532800": {"Name": "Bittner T.", "AuthorID": "16644532800", "AffiliationID": "60072289", "AffiliationName": "Roche Diagnostics GmbH"}, "55661859900": {"Name": "Eichenlaub U.", "AuthorID": "55661859900", "AffiliationID": "60072289", "AffiliationName": "Roche Diagnostics GmbH"}, "57023617000": {"Name": "Heiss P.", "AuthorID": "57023617000", "AffiliationID": "60072289", "AffiliationName": "Roche Diagnostics GmbH"}, "6602520531": {"Name": "Kobold U.", "AuthorID": "6602520531", "AffiliationID": "60072289", "AffiliationName": "Roche Diagnostics GmbH"}, "24070740000": {"Name": "Leinenbach A.", "AuthorID": "24070740000", "AffiliationID": "60072289", "AffiliationName": "Roche Diagnostics GmbH"}, "6602385003": {"Name": "Madin K.", "AuthorID": "6602385003", "AffiliationID": "60072289", "AffiliationName": "Roche Diagnostics GmbH"}, "57023734500": {"Name": "Manuilova E.", "AuthorID": "57023734500", "AffiliationID": "60072289", "AffiliationName": "Roche Diagnostics GmbH"}, "55584131500": {"Name": "Rabe C.", "AuthorID": "55584131500", "AffiliationID": "60072289", "AffiliationName": "Roche Diagnostics GmbH"}, "6701454676": {"Name": "Zetterberg H.", "AuthorID": "6701454676", "AffiliationID": "60019953", "AffiliationName": "UCL Institute of Neurology"}, "6507790467": {"Name": "Andreasson U.", "AuthorID": "6507790467", "AffiliationID": "60027675, 60016437", "AffiliationName": "Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg"}, "56415176000": {"Name": "Blennow K.", "AuthorID": "56415176000", "AffiliationID": "60027675, 60016437", "AffiliationName": "Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg"}, "6701704380": {"Name": "Teunissen C.E.", "AuthorID": "6701704380", "AffiliationID": "60001997", "AffiliationName": "Clinical Chemistry, VU University Medical Center"}, "7801459393": {"Name": "Hubeek I.", "AuthorID": "7801459393", "AffiliationID": "60001997", "AffiliationName": "Clinical Chemistry, VU University Medical Center"}, "7005634928": {"Name": "Ostlund R.E.", "AuthorID": "7005634928", "AffiliationID": "60022756", "AffiliationName": "Washington University School of Medicine"}, "55767601300": {"Name": "Gibson D.", "AuthorID": "55767601300", "AffiliationID": "60022756", "AffiliationName": "Washington University School of Medicine"}, "57023697300": {"Name": "Militello M.", "AuthorID": "57023697300", "AffiliationID": "100388403", "AffiliationName": "Covance Central Laboratory Services"}, "57023030100": {"Name": "Chu D.C.", "AuthorID": "57023030100", "AffiliationID": "100388403", "AffiliationName": "Covance Central Laboratory Services"}}}